Learn about Vanderbilt’s CTSA and how it supports VICTR’s mission

VICTR - the Vanderbilt CTSA

The first CTSA’s were awarded to 12 academic medical centers in September 2006. Vanderbilt’s CTSA, known as VICTR - The Vanderbilt Institute for Clinical and Translational Research, was funded during the second round of awards in September of 2007.

Each CTSA is led by a principal investigator, an established clinician scientist, who has the primary responsibility to define objectives and approaches of the CTSA and to oversee the CTSA at a local level as well as collaborate with the national CTSA consortium.Vanderbilt’s CTSA principal investigator, program director, and VICTR director is Gordon R. Bernard, M.D.

A major goal of VICTR is to remove roadblocks to translational science (i.e. moving scientific discoveries from bench to bedside).  VICTR functions to help researchers and clinicians do their jobs better by providing tools and support to improve the quality of research, publications, grant writing, and training for future doctors and researchers.

Click on the links below to read announcements about the Vanderbilt CTSA:

The Reporter:  VUMC to Lead National CTSA Consortium

Promoting Translational Research at Vanderbilt University's CTSA Institute

The Reporter:  Clinical Research Gets Massive Boost

Vanderbilt's CTSA lands $46 million renewal



Questions, Comments, Suggestions...

Ask a question about VICTR or the CTSA
or provide comments or suggestions
regarding this website. Include your name and address if you wish to receive a response.

Type characters above to submit